Gary O'Donovan Email and Phone Number
Gary O'Donovan work email
- Valid
- Valid
Gary O'Donovan personal email
- Valid
As a Senior Scientist II at AbbVie, I contribute the design, synthesis, and screening evaluation of DNA-encoded libraries (DELs) for various therapeutic targets. DEL technology is a powerful and innovative platform for drug discovery that I have been working with for over twenty years, currently at AbbVie. With a BSc degree in Chemistry of Pharmaceutical Compounds and a strong background in medicinal chemistry, biochemistry, and oligonucleotide synthesis, I have contributed to publications in the field of DEL technology and its applications for infectious diseases, such as tuberculosis and malaria. I am passionate about advancing the science and technology of DELs and collaborating with multidisciplinary teams to discover novel and effective compounds for unmet medical needs. I am also committed to learning new skills, staying updated on the latest developments, and sharing my knowledge and experience with others. I constantly seek opportunities to leverage my expertise and competencies in DEL technology and medicinal chemistry to create value and impact for AbbVie and its customers.
-
Senior Scientist Ii, Target Enabling Technology-Dna Encoded LibraryAbbvie Jul 2023 - PresentNorth Chicago, Illinois, Us
-
Senior Scientist I, Augmented Molecular Design & Target Enabling Technology-Dna Encoded LibraryAbbvie Mar 2020 - Jul 2023North Chicago, Illinois, Us
-
Scientific Consultant, Dna Encoded Library TechnologyDelscovery Llc Oct 2019 - Mar 2020• Initiated scientific consulting projects for small and medium biotech organizations in DNA Encoded Library Technology, driving lead generation for therapeutic targets.• Developed and implemented innovative strategies to meet client needs and enhance outsourcing capabilities in DEL technology.• Collaborated with cross-functional teams to deliver high-quality scientific consulting services, contributing to the growth of DELscovery. -
Scientist, Medicinal Chemistry; Dna Encoded LibraryDice Therapeutics, An Eli Lilly Company Jan 2018 - Oct 2019• Developed novel strategies in medicinal chemistry utilizing DNA-encoded libraries and combinatorial chemistry techniques.• Contributed to cross-functional teams to drive innovation in drug discovery at DICE Therapeutics.• Achieved successful integration of directed biological evolution with chemistry technologies for drug development.• Contributed to the advancement of drug discovery processes at a startup environment in Redwood City, California.
-
Scientist, Dna Encoded Library TechnologyNurix Therapeutics May 2016 - Dec 2017San Francisco, Ca, Us• Led a team in synthesizing DNA encoded libraries for drug discovery platform based on UPS.• Developed innovative strategies for library synthesis to enhance drug discovery process.• Collaborated with cross-functional teams to optimize library design and screening processes. -
Senior Scientist, Chemistry-Dna Encoded Library TechnologyGsk Feb 2007 - May 2016Brentford, Middlesex, Gb• Contributed to the design and synthesis of DNA Encoded Libraries for hit identification.• Utilized traditional organic synthesis methods for post affinity selection synthesis of chemical hits.• Synthesized Oligonucleotides/Aptamers using Mermade instrumentation. -
Scientist, Dna Encoded Library TechnologyPraecis Pharmaceuticals Sep 2006 - Feb 2007UsDNA Encoded Library Synthesis Chemist(Praecis was acquired by GSK in early 2007) -
Chemistry Intern-Direct Select/Dna Encoded Library TechnologyPraecis Pharmaceuticals Sep 2003 - Aug 2004Us• Developed Direct Select technology for creating vast libraries of drug-like molecules to identify lead compounds with higher affinity and specificity.• Contributed to the development of new chemistries and chemical scaffolds, resulting in numerous ultra-large libraries.• Praecis Pharmaceuticals was acquired by GlaxoSmithKline in 2007, rebranding Direct Select technology as Encoded Library Technology (ELT).
-
Scientist, Process DevelopmentThe Janssen Pharmaceutical Companies Of Johnson & Johnson 2001 - 2002Raritan, New Jersey, UsOptimized chemical syntheses of a neuroleptic drug.
Gary O'Donovan Skills
Gary O'Donovan Education Details
-
University College CorkMedicinal And Pharmaceutical Chemistry -
Drew UniversityResidential School On Medicinal Chemistry And Biology In Drug Discovery 2018
-
Colby-Sawyer CollegeHigh Throughput Chemistry & Chemical Biology- Grc
-
Kinsale Community School, Co Cork. Ireland
Frequently Asked Questions about Gary O'Donovan
What company does Gary O'Donovan work for?
Gary O'Donovan works for Abbvie
What is Gary O'Donovan's role at the current company?
Gary O'Donovan's current role is Senior Scientist II @ AbbVie | DNA Encoded Library, Target Enabling Technology.
What is Gary O'Donovan's email address?
Gary O'Donovan's email address is ga****@****ail.com
What schools did Gary O'Donovan attend?
Gary O'Donovan attended University College Cork, Drew University, Colby-Sawyer College, Kinsale Community School, Co Cork. Ireland.
What are some of Gary O'Donovan's interests?
Gary O'Donovan has interest in Human Rights, Science And Technology, Environment, Health.
What skills is Gary O'Donovan known for?
Gary O'Donovan has skills like Chemistry, Medicinal Chemistry, Drug Discovery, Organic Chemistry, Lc Ms, Dna, Laboratory, Hplc, Biochemistry, Process Simulation, Drug Development, Organic Synthesis.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial